文献速递肾癌与肾肿瘤

种族与透明细胞肾细胞癌患者5年生存期的关联:队列研究

The Association Between Race and 5-year Survival in Patients With Clear Cell Renal Cell Carcinoma: A Cohort Study.
PubMed 文献 · Urology · 2020-12-05

该队列研究基于SEER数据库2007-2015年13个州的数据,纳入8421例透明细胞肾细胞癌患者,采用Cox回归分析种族与5年病因特异性生存的关联。调整协变量后,种族与5年病因特异性生存无显著关联(黑人HR 0.96,95%CI 0.83-1.12;美洲印第安人/阿拉斯加原住民HR 1.01,95%CI 0.75-1.36;亚太岛民HR 0.99,95%CI 0.82-1.12)。作者认为黑人群体的总体生存劣势可能由社会健康决定因素而非肾癌特异性因素驱动。

要点

  • 调整协变量后,种族与透明细胞肾细胞癌5年病因特异性生存无显著关联。
  • 高龄及区域或远处肿瘤患者死亡风险增加,女性和有保险者死亡风险降低。
  • 黑人肾癌总体生存劣势可能反映社会健康决定因素而非肿瘤特异性因素。

核心结论

  • 种族与透明细胞肾细胞癌5年病因特异性生存无显著关联。
  • 黑人肾癌总体生存劣势可能由社会健康决定因素驱动,而非肾癌特异性因素。

研究设计与样本

  • 基于SEER数据库2007-2015年13个州数据的队列研究,共纳入8421例透明细胞肾细胞癌患者。
  • 采用Cox回归模型计算风险比(HR)及95%置信区间(CI),并调整协变量。

主要发现

  • 调整后黑人HR 0.96(95%CI 0.83-1.12),美洲印第安人/阿拉斯加原住民HR 1.01(95%CI 0.75-1.36),亚太岛民HR 0.99(95%CI 0.82-1.12)。
  • 高龄及区域或远处肿瘤患者死亡风险增加,女性和有保险患者死亡风险降低。

临床怎么用

  • 临床评估肾癌预后时应关注社会健康决定因素而非仅种族因素。
  • 需结合保险状态、合并症、教育程度和医疗可及性等综合评估。

局限性

  • SEER数据库缺乏收入、合并症、教育状态和医疗可及性等信息。
  • 作者指出需更大样本量并纳入上述因素的研究进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine if race was associated with 5-year cause-specific survival in patients with clear cell renal cell carcinoma. MATERIALS AND METHODS: Outcomes were investigated using the Surveillance Epidemiology and End Results database with data from 13 states between the years 2007-2015. Covariates included age, sex, insurance, marital status, and tumor stage at diagnosis. Patients <18 years old or with missing data for race, survival time or insurance status were excluded. Cox regression models were used to determine associations through hazard ratios (HR) with 95% confidence intervals (CI) and to adjust for covariates. RESULTS: A total of 8421 subjects were included in the analysis. After adjustment, there was no association between race and 5-year cause-specific survival in patients with ccRCC (Black- HR: 0.96, 95%CI: 0.83,1.12; American Indian/Alaskan- HR: 1.01, 95%CI: 0.75,1.36; Asian Pacific Islander- HR: 0.99, 95%CI: 0.82,1.12). Older individuals and those with regional or distant tumors showed an increased hazard of death, while females and insured patients showed decreased hazard. CONCLUSION: Our study found that race was not associated with 5-year cause-specific survival from clear cell renal cell carcinoma. However inferior overall survival in Blacks with RCC has been well demonstrated in the literature. Our findings suggest that differences in survival may not be driven by cause-specific factors such as renal cell carcinoma, but rather social determinants of health which disproportionality affect Black patients. Further studies with more power that incorporate information on income, comorbidities, education status, and access to care are therefore necessary.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Jivanji D, Jamieson S, Mallory C, et al. The Association Between Race and 5-year Survival in Patients With Clear Cell Renal Cell Carcinoma: A Cohort Study. Urology. 2020. PMID: 33285213. doi:10.1016/j.urology.2020.10.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。